These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

122 related items for PubMed ID: 3492229

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Effects of administration of estrogen or diphenylhydantoin on the kinetics of diphenylhydantoin in man.
    Fernandez-Pol JA, Zaninovich AA.
    J Nucl Med; 1975 Apr; 16(4):305-8. PubMed ID: 803558
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. 5,5'-Diphenylhydantoin decreases specific 3,5,3'-triiodothyronine (T3) binding by rat hepatic nuclear T3 receptors.
    Mann DN, Surks MI.
    Endocrinology; 1983 May; 112(5):1723-31. PubMed ID: 6299706
    [Abstract] [Full Text] [Related]

  • 7. Diphenylhydantoin stimulates the intrapituitary conversion of thyroxine to triiodothyronine in the rat.
    Cageao LF, Ceppi JA, Boado RJ, Zaninovich AA.
    Neuroendocrinology; 1992 Oct; 56(4):453-8. PubMed ID: 1475006
    [Abstract] [Full Text] [Related]

  • 8. Octapeptides deduced from the neuropeptide receptor-like pattern of antigen T4 in brain potently inhibit human immunodeficiency virus receptor binding and T-cell infectivity.
    Pert CB, Hill JM, Ruff MR, Berman RM, Robey WG, Arthur LO, Ruscetti FW, Farrar WL.
    Proc Natl Acad Sci U S A; 1986 Dec; 83(23):9254-8. PubMed ID: 3097649
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. 5,5'-Diphenylhydantoin (phenytoin) attenuates the action of 3,5,3'-triiodo-L-thyronine in cultured GC cells.
    Gingrich SA, Smith PJ, Shapiro LE, Surks MI.
    Endocrinology; 1985 Jun; 116(6):2306-13. PubMed ID: 3996315
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. The effect of diphenylhydantoin and cortisol on the cell cycle.
    MacKinney AA, Knobeloch L, Norback D.
    Proc Soc Exp Biol Med; 1988 Jun; 188(2):173-6. PubMed ID: 3375264
    [Abstract] [Full Text] [Related]

  • 19. Diphenylhydantoin inhibits osteoclast differentiation and function through suppression of NFATc1 signaling.
    Koide M, Kinugawa S, Ninomiya T, Mizoguchi T, Yamashita T, Maeda K, Yasuda H, Kobayashi Y, Nakamura H, Takahashi N, Udagawa N.
    J Bone Miner Res; 2009 Aug; 24(8):1469-80. PubMed ID: 19292614
    [Abstract] [Full Text] [Related]

  • 20. 5,5'-Diphenylhydantoin decreases the entry of 3,5,3'-triiodo-L-thyronine but not L-thyroxine in cultured GH-producing cells.
    Zemel LR, Biezunski DR, Shapiro LE, Surks MI.
    Acta Endocrinol (Copenh); 1988 Mar; 117(3):392-8. PubMed ID: 3381641
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.